Vaginal pessaries are devices inserted into the vagina to support pelvic organs. Common vaginal pessaries include ring pessary, shelf pessary, and Gellhorn pessary. Vaginal pessaries are used to treat pelvic organ prolapse conditions. Pelvic organ prolapse occurs when pelvic organs such as the uterus, bladder, small bowel, and rectum slip down from their normal position due to weakness in the muscles and tissues that hold them in place. Vaginal pessaries provide comfortable, non-surgical treatment for pelvic organ prolapse conditions.
The global vaginal pessary market is estimated to be valued at US$ 357.36 Bn in 2023 and is expected to exhibit a CAGR of 10.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing prevalence of pelvic organ prolapse due to various factors such as obesity, childbirth injuries, menopause, and chronic cough is a major driver of the vaginal pessary market. According to the Pelvic Organ Prolapse Fact Sheet published by the Office on Women’s Health, around 3-4% of women in the US suffer from pelvic organ prolapse. Vaginal pessaries are the first-line treatment option for pelvic organ prolapse, especially for the mild to moderate cases. Their non-surgical nature makes them preferable to procedures such as surgeries. This high preference for non-surgical treatments over invasive surgeries is fueling growth of the vaginal pessary market.
Strength: Vaginal pessaries offer a non-invasive and painless solution for pelvic organ prolapse and urinary incontinence. They are easy to use and have minimal side effects.
Weakness: Some women experience discomfort while wearing pessaries. They also require regular monitoring and replacement which can be inconvenient.
Opportunity: Rising elderly population susceptible to conditions like prolapse augments demand. Initiatives to raise awareness about treatment options present an opportunity.
Threats: Alternative treatment choices like pelvic floor exercises and surgeries pose competition. Stringent regulatory norms for approval delays new product launches.
Global Vaginal Pessary Market Demand is expected to witness high growth over the forecast period. The North American region currently dominates the market due to high awareness levels and availability of advanced treatment options. The region is expected to maintain its lead position during the forecast period supported by rising healthcare expenditure. The Asia Pacific region is expected to emerge as the fastest growing market for vaginal pessaries. This can be attributed to increasing cases of urinary incontinence among women coupled with growing medical tourism in countries like India and China.
Key players operating in the vaginal pessary market are CooperSurgical, Inc., MedGyn Products, Inc., Thomas Medical, Inc., Smiths Medical, Milex Products, Inc., Personal Medical Corp., Panpac Medical Corp., Gyneas, Uromed Kurt Drews KG, Integra LifeSciences Corporation, Boston Scientific Corporation, Cook Medical, Medtronic plc, C. R. Bard, Inc. (BD), and Coloplast A/S. Leading manufacturers are focusing on developing innovative product designs and expanding to emerging markets to strengthen their market position.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it